Taking people in GermanyNo phase
Vercise™ DBS Dystonia Prospective Study
Key facts
- Where
- Berlin, Cologne, Düsseldorf, Freiburg im Breisgau, Hamburg, Hamm, Hanover, Kiel, Mainz, Marburg, Oldenburg, and Würzburg, GermanySee the 12 sites
Where in Germany
- University Berlin, Charite Virchow Standort, WeddingBerlin, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- Uniklinik KölnCologne, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- Universitaetsklinikum DusseldorfDüsseldorf, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- Universitaetsklinikum FreiburgFreiburg im Breisgau, GermanyContact: Boston Scientific Clinical ResearchTaking people
- Universitaetsklinik EppendorfHamburg, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- St. Barbara-Klinik Hamm-HeessenHamm, GermanyContact: Stephanie DelvauxNo longer taking part
- Medizinische Hochschule Hannover (MHH)Hanover, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- Universitätsklinikum Campus KielKiel, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- Johannes Gutenberg Universitaet MainzMainz, GermanyContact: Stephanie DelvauxNo longer taking part
- Universitaetsklinikum Giessen und Marburg GmbHMarburg, GermanyContact: Boston Scientific Clinical Research ManagerTaking people
- Evangelisches Krankenhaus OldenburgOldenburg, GermanyContact: Stephanie DelvauxNo longer taking part
- Universitaetsklinikum WuerzburgWürzburg, GermanyContact: Boston Scientific Clinical ResearchTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Boston Scientific Corporation
- Trial code
- NCT02686125
- Record updated
- 13 October 2026
- Original description
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.Read full original descriptionShow less
Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.
Inclusion: IC1. Meets criteria established in the locally applicable Vercise System Directions for Use (DFU) for dystonia; IC2. At least 7 years old. Parent or guardian consent is required in patients who are younger than 18 years at the time of consent.
Exclusion: EC1. Meets any contraindication in the Vercise System locally applicable Directions for Use.